EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹399 Cr | ₹295 Cr | ₹239 Cr | ₹268 Cr | ₹267 Cr |
What is the latest Short Term Loans and Advances ratio of EMCURE PHARMACEUTICALS ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹399 Cr |
| Mar2025 | ₹295 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹268 Cr |
| Mar2022 | ₹267 Cr |
How is Short Term Loans and Advances of EMCURE PHARMACEUTICALS Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹399 Cr | 34.97 | |
| Mar2025 | ₹295 Cr | 23.50 | |
| Mar2024 | ₹239 Cr | -10.62 | |
| Mar2023 | ₹268 Cr | 0.38 | |
| Mar2022 | ₹267 Cr | - | |
Compare Short Term Loans and Advances of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,217.8 Cr | 0.5% | -5.1% | 25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0.5% |
-5.1% |
25.4% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses